Related references
Note: Only part of the references are listed.Genetically Engineered Lipopeptide Antibiotics Related to A54145 and Daptomycin with Improved Properties
Kien T. Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Daptomycin: From the Mountain to the Clinic, with Essential Help from Francis Tally, MD
Barry I. Eisenstein et al.
CLINICAL INFECTIOUS DISEASES (2010)
Genomic basis for natural product biosynthetic diversity in the actinomycetes
Markus Nett et al.
NATURAL PRODUCT REPORTS (2009)
Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia
Peter E. Pertel et al.
CLINICAL INFECTIOUS DISEASES (2008)
Renaissance in antibacterial discovery from actinomycetes
Richard H. Baltz
CURRENT OPINION IN PHARMACOLOGY (2008)
Biosynthesis and genetic engineering of lipopeptide antibiotics related to daptomycin
Richard H. Baltz
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Role of DptE and DptF in the lipidation reaction of daptomycin
Melanie Wittmann et al.
FEBS JOURNAL (2008)
Stereospecific enzymatic transformation of α-ketoglutarate to (2S,3R)-3-methyl glutamate during acidic lipopeptide biosynthesis
Christoph Mahlert et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Polyketide synthases and nonribosomal peptide synthetases: the emerging view from bacterial genomics
Stefano Donadio et al.
NATURAL PRODUCT REPORTS (2007)
Combinatorial biosynthesis of novel antibiotics related to daptomycin
Kien T. Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A glutamic acid 3-methyltransferase encoded by an accessory gene locus important for daptomycin biosynthesis in Streptomyces roseosporus
Kien T. Nguyen et al.
MOLECULAR MICROBIOLOGY (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Assembly-line enzymology for polyketide and nonribosomal peptide antibiotics: Logic, machinery, and mechanisms
Michael A. Fischbach et al.
CHEMICAL REVIEWS (2006)
Genetic engineering in Streptomyces roseosporus to produce hybrid lipopeptide antibiotics
V Miao et al.
CHEMISTRY & BIOLOGY (2006)
The lipopeptide antibiotic A54145 biosynthetic gene cluster from Streptomyces fradiae
V Miao et al.
JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY (2006)
Inhibition of daptomycin by pulmonary surfactant: In vitro modeling and clinical impact
JA Silverman et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
An acyl-CoA dehydrogenase is involved in the formation of the Δcis3 double bond in the acyl residue of the lipopeptide antibiotic friulimicin in Actinoplanes friuliensis
E Heinzelmann et al.
MICROBIOLOGY-SGM (2005)
Daptomycin biosynthesis in Streptomyces roseosporus:: cloning and analysis of the gene cluster and revision of peptide stereochemistry
V Miao et al.
MICROBIOLOGY-SGM (2005)
Natural products to drugs: daptomycin and related lipopeptide antibiotics
RH Baltz et al.
NATURAL PRODUCT REPORTS (2005)
Specificity prediction of adenylation domains in nonribosomal peptide synthetases (NRPS) using transductive support vector machines (TSVMs)
C Rausch et al.
NUCLEIC ACIDS RESEARCH (2005)
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
RD Arbeit et al.
CLINICAL INFECTIOUS DISEASES (2004)
Structure, biosynthetic origin, and engineered biosynthesis of calcium-dependent antibiotics from Streptomyces coelicolor
Z Hojati et al.
CHEMISTRY & BIOLOGY (2002)
Predictive, structure-based model of amino acid recognition by nonribosomal peptide synthetase adenylation domains
GL Challis et al.
CHEMISTRY & BIOLOGY (2000)
Share Paper
